
Hikma Pharmaceuticals Hits Day Low of GBP 15.22 Amid Price Pressure
2025-11-07 17:07:10Hikma Pharmaceuticals Plc has faced notable stock volatility, hitting an intraday low and experiencing significant declines over various timeframes. Despite maintaining high management efficiency and a low debt-to-equity ratio, the company is challenged by rising raw material costs and a substantial drop in pre-tax profit.
Read More
Hikma Pharmaceuticals Hits Day High with Strong 6.66% Intraday Surge
2025-10-01 17:29:31Hikma Pharmaceuticals Plc has seen a significant rise in its stock price today, contrasting with the modest gains of the FTSE 100. Despite recent improvements, the company's year-to-date performance remains negative, and it faces challenges such as rising raw material costs and a decline in pre-tax profits.
Read MoreNo announcement available
Corporate Actions
No corporate action available






